Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

CYCCP Cyclacel Pharmaceuticals Inc

10,70

3,20 (42,67%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:48:30

Verzögert um 15 Minuten

$8 Million Private Placement Announcement Sends Biotech Flying

Usually when a publicly traded company announces some sort of equity offering, it can be viewed as a dilutive event, thus having a negative effect on the company’s price per...

To read the full story on AllPennyStocks.com, click here.

Cyclacel Pharmaceuticals (NASDAQ:CYCCP)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Cyclacel Pharmaceuticals Charts.

Cyclacel Pharmaceuticals (NASDAQ:CYCCP)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Cyclacel Pharmaceuticals Charts.

News Cyclacel Pharmaceuticals Inc

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
Mittwoch 26 Juni 2024 (1 Tag vor) • GlobeNewswire Inc.

Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting
Dienstag 4 Juni 2024 (3 Wochen vor) • GlobeNewswire Inc.

Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib’s Potential as a Precision Medicine for Cancer
Montag 3 Juni 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities
Freitag 17 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 14 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update
Dienstag 14 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Montag 13 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
Mittwoch 8 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mittwoch 8 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Mittwoch 8 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Montag 6 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Cyclacel Pharmaceuticals Inc News-Artikel

BNP Paribas Issuance

Amundiprime Usa

PETRG1 Ex:30,67

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen